These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22488416)

  • 21. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments.
    Nathan RA
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):182-90; quiz 190-1, 232. PubMed ID: 12602664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
    Bartra J; Mullol J; Montoro J; Jáuregui I; del Cuvillos A; Dávila I; Ferrer M; Sastre J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():24-33. PubMed ID: 22185047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.
    Lai DS; Lue KH; Hsieh JC; Lin KL; Lee HS
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of intranasal corticosteroids for the ocular symptoms of allergic rhinitis: A systematic review.
    Hong J; Bielory B; Rosenberg JL; Bielory L
    Allergy Asthma Proc; 2011; 32(1):22-35. PubMed ID: 21262095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of nasal corticosteroids in the treatment of rhinitis.
    Meltzer EO
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):545-60. PubMed ID: 21737042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials.
    Penagos M; Compalati E; Tarantini F; Baena-Cagnani CE; Passalacqua G; Canonica GW
    Allergy; 2008 Oct; 63(10):1280-91. PubMed ID: 18721246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open label, active controlled, multicentric clinical trial to assess the efficacy and safety of fluticasone furoate nasal spray in adult Indian patients suffering from allergic rhinitis.
    Kubavat AH; Pawar P; Mittal R; Sinha V; Shah UB; Ojha T; Khippal N; Patel T
    J Assoc Physicians India; 2011 Jul; 59():424-8. PubMed ID: 22315746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal corticosteroids topical characteristics: side effects, formulation, and volume.
    Petty DA; Blaiss MS
    Am J Rhinol Allergy; 2013; 27(6):510-3. PubMed ID: 24274228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of intranasal corticosteroids.
    Grzincich G; Capra L; Cammarata MG; Spaggiari C; Pisi G
    Acta Biomed; 2004 Apr; 75(1):22-5. PubMed ID: 15315083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal mometasone furoate alleviates the ocular symptoms associated with seasonal allergic rhinitis: results of a post hoc analysis.
    Anolik R; Nathan RA; Schenkel E; Danzig MR; Gates D; Varghese S
    Int Arch Allergy Immunol; 2008; 147(4):323-30. PubMed ID: 18622139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
    Bernstein JA
    Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting congestion in allergic rhinitis: the importance of intranasal corticosteroids.
    Marple BF
    Allergy Asthma Proc; 2008; 29(3):232-40. PubMed ID: 18534080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.
    Abelson MB; Gomes PJ; Vogelson CT; Pasquine TA; Turner FD; Wells DT; Robertson SM
    Curr Med Res Opin; 2005 May; 21(5):683-91. PubMed ID: 15969867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis.
    Kalpaklioglu AF; Kavut AB
    Am J Rhinol Allergy; 2010; 24(1):29-33. PubMed ID: 20109317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular symptom efficacy and intranasal corticosteroids.
    Keith PK; Toler WT; Lee LA
    Ann Allergy Asthma Immunol; 2009 Dec; 103(6):539; author reply 539-40. PubMed ID: 20084852
    [No Abstract]   [Full Text] [Related]  

  • 36. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep.
    Meltzer EO; Munafo DA; Chung W; Gopalan G; Varghese ST
    Ann Allergy Asthma Immunol; 2010 Jul; 105(1):65-74. PubMed ID: 20642206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis.
    Lee TA; Pickard AS
    Pharmacotherapy; 2007 Jun; 27(6):852-9. PubMed ID: 17542768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
    Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
    Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How do topical nasal corticosteroids improve sleep and daytime somnolence in allergic rhinitis?
    Craig TJ; Hanks CD; Fisher LH
    J Allergy Clin Immunol; 2005 Dec; 116(6):1264-6. PubMed ID: 16337455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis.
    Meltzer EO
    Ann Allergy Asthma Immunol; 2007 Jan; 98(1):12-21. PubMed ID: 17225715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.